Neurensin-1 inhibitors are a class of compounds that specifically target and inhibit the activity of Neurensin-1, a protein that is implicated in various cellular functions within the nervous system. The protein itself is a member of the small, soluble, intracellular lipid-binding protein (iLBPs) family, believed to be involved in the intracellular transport of small hydrophobic molecules, including signaling lipids which play crucial roles in maintaining neuronal integrity and function. Inhibitors of Neurensin-1 work by binding to the protein in a manner that obstructs its normal function, potentially altering the intracellular distribution and concentrations of its lipid cargo. The exact binding sites and inhibition mechanisms can be diverse, depending on the molecular structure of the inhibitor and its physicochemical properties, such as shape, charge, and hydrophobicity.
To elucidate the specifics of how Neurensin-1 inhibitors interact with their target, researchers employ various biochemical and biophysical techniques. For instance, assays that measure the binding affinity and kinetics of these inhibitors can reveal how tightly and quickly an inhibitor associates with and dissociates from Neurensin-1. Additionally, structural studies using methods like X-ray crystallography or cryo-electron microscopy can provide a detailed three-dimensional picture of the inhibitor-bound protein, shedding light on the precise molecular interactions responsible for inhibition.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Inhibitor of N-WASP, affecting actin polymerization, potentially altering the cellular environment where Neurensin-1 operates. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, may affect Neurensin-1 by altering downstream signaling pathways involved in neuronal survival and function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, can influence MAPK/ERK pathway, potentially modifying the cellular context and affecting Neurensin-1 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, can modify the stress response pathways that might intersect with Neurensin-1's role in neurons. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, can alter the JNK signaling pathway, which may intersect with Neurensin-1's functioning in neurons. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
CaMKII inhibitor, can influence calcium signaling pathways, potentially affecting the cellular processes involving Neurensin-1. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
PKC inhibitor, can change protein kinase C activity, possibly influencing signaling pathways where Neurensin-1 is active. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that may modulate cytoskeletal dynamics, potentially affecting Neurensin-1's role in neurons. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $68.00 $267.00 | 10 | |
Calcium chelator, can change intracellular calcium levels, potentially influencing Neurensin-1's activity or localization. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor, can elevate intracellular calcium levels, potentially influencing Neurensin-1's role in neurons. | ||||||